Expression and clinicopathologic significance of proteolysis-inducing factor in non-small-cell lung cancer: An immunohistochemical analysis

Clinical Lung Cancer

Volumn 11, Issue 5, 2010, Pages 346-351

  Wang, Qing ^a   Lu, Ji Bin ^a   Wu, Bin ^a,b   Hao, Li Ying ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Department of Thoracic Surgery   (China)

Author keywords

Cachexia; CYFRA 21 1; Survival; Weight loss

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; GLYCOPROTEIN; PROTEOLYSIS INDUCING FACTOR; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CACHEXIA; CANCER STAGING; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; WEIGHT REDUCTION;

EID: 77957071610     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2010.n.044     Document Type: Article

References (23)

1. De Wys WD. Weight loss and nutritional abnormalities in cancer patients: Incidence, severity and significance. In: Calman KC, Fearon KCH, eds. Clinics in Oncology. Vol 5. London: W.B. Saunders; 1986:115-126
2. Williams ML, Torres-Duarte A, Brant LJ, et al. The relationship between a urinary cachectic factor and weight loss in advanced cancer patients. Cancer Invest 2004; 22:866-870
3. Fearon KC. The Sir David Cuthbertson Medal Lecture 1991. The mechanisms and treatment of weight loss in cancer. Proc Nutr Soc 1992; 51:251-265
4. Lorite MJ, Smith HJ, Arnold JA, et al. Activation of ATP-ubiquitin- dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF). Br J Cancer 2001; 85:297-302.
5. Todorov PT, Cariuk P, McDevitt T, et al. Characterization of a cancer cachectic factor. Nature 1996; 379:739-742
6. Todorov PT, Deacon M, Tisdale MJ. Structural analysis of a tumor-produced sulfated glycoprotein capable of initiating muscle protein degradation. J Biol Chem 1997; 272:12279-12288
7. Cariuk P, Lorite MJ, Todorov PT, et al. Induction of cachexia in mice by a product isolated from the urine of cachectic cancer patients. Br J Cancer 1997; 76:606-613
8. Cabal-Manzano R, Bhargava P, Torres-Duarte A, et al. Proteolysis-inducing factor is expressed in tumours of patients with gastrointestinal cancers and correlates with weight loss. Br J Cancer 2001; 84:1599-1601
9. Cunningham TJ, Jing H, Akerblom I, et al. Identification of the human cDNA for new survival/evasion peptide (DSEP): studies in vitro and in vivo of overexpression by neural cell. Exp Neurol 2002; 177:32-39
10. Cummings RD, Kornfeld S, Schneider WJ, et al. Biosynthesis of N- and O-linked oligosaccharides of the low density lipoprotein receptor. J Biol Chem 1983; 258:15261-15273
11. Teich N, Kleeff J, Lochs H, et al. The presence of the proteolysis-inducing factor in urine does not predict the malignancy of a pancreatic tumour. BMC Gastroenterol 2005; 21:5-20.
12. Jatoi A, Foster N, Wieland B, et al. The proteolysis-inducing factor: in search of its clinical relevance in patients with metastatic gastric/esophageal cancer. Dis Esophagus 2006; 19:241-247
13. Giordano KF, Jatoi A. The anorexia/weight loss syndrome: therapeutic challenges. Curr Oncol Rep 2005; 7:271-276
14. Tisdale MJ. Molecular pathways leading to cancer cachexia. Physiology (Bethesda) 2005; 20:340-348
15. Wigmore SJ, Todorov PT, Barber MD, et al. Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor. Br J Surg 2000; 87:53-58
16. Monitto CL, Dong SM, Jen J, et al. Characterization of a human homologue of proteolysis-inducing factor and its role in cancer cachexia. Clin Cancer Res 2004; 10:5862-5869
17. Pujol JL, Grenier J, Dours JP, et al. Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res 1993; 53:61-66
18. Dohmoto K, Hojo S, Fujita J, et al. Mechanisms of the release of CYFRA 21-1 in human lung cancer cell lines. Lung Cancer 2000; 30:55-63.
19. Sheard MA, Vojtesek B, Simickova M, et al. Release of cytokeratin-18 and -19 fragments (TPS and CYFRA 21-1) into the extracellular space during apoptosis. J Cell Biochem 2002; 85:670-677
20. Wieland BM, Stewart GD, Skipworth RJ, et al. Is there a human homologue to the murine proteolysis-inducing factor? Clin Cancer Res 2007; 13:4984-4992
21. Rennie MJ, Edwards RH, Emery PW, et al. Depressed protein synthesis is the dominant characteristic of muscle wasting and cachexia. Clin Physiol 1983; 3:387-398
22. Lundholm K, Bennegrd K, Edn E, et al. Efflux of 3-methylhistidine from the leg in cancer patients who experience weight loss. Cancer Res 1982; 42:4807-4811
23. Todorov PT, Wyke SM, Tisdale MJ. Identification and characterization of a membrane receptor for proteolysis-inducing factor on skeletal muscle. Cancer Res 2007; 67:11419-11427